News

Seven years after opening, the Frances and Stephen Foster Center for Ocular Immunology at Duke Eye Center has made great strides in advancing the evaluation, diagnosis, treatment, and research of inflammatory eye diseases.

In a recent episode of the Healio Mend the Gap: Equality in Medicine podcast, Laura Enyedi, MD joined Cathleen McCabe, MD, and guest Anna Momont, MD, for a thoughtful conversation on resilience in medicine.

We are proud of our retina faculty for their outstanding contributions at the FLORetina Meeting, held December 4–7, 2025, in Florence, Italy.

We are proud to announce that several of our talented ophthalmic photographers earned top honors at this year’s Ophthalmic Photographers’ Society Image Awards during the 2025 American Academy of Op

In a recent Ophthalmology Times commentary, Laura B.

Duke Eye Center faculty were among the invited speakers at the 7th Biennial International Symposium on Age-Related Macular Degeneration (AMD), held October 24–25, 2025, in Cambridge, MA.

For years, glaucoma was robbing Josie Paige’s vision despite two surgeries to halt her rising eye pressure. In February 2025, Duke Health glaucoma specialist Leon Herndon, MD, inserted a device in her left eye that Duke-published research showed was more effective at reducing eye pressure than the standard of care. Paige’s eye pressure dropped, and her prognosis is good. “There’s no cure for glaucoma,” Dr. Herndon said, “but she should keep her sight for the rest of her life.”

Laura Enyedi, MD co-hosted a special live episode of Healio’s Mend the Gap: Equity in Medicine podcast wi

When Yvette retired, she dreamed of traveling the country in her RV. Then a rare eye disease threatened to take away her independence.

A team at Duke Eye Center is the first team at a U.S. academic medical center to implant a new commercially available cell-based gene therapy for a rare, but debilitating, retinal disorder called macular telangiectasia type 2, or MacTel.